Consolidated Balance Sheets - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Current assets
Cash and cash equivalents	$ 1,340,203	$ 732,542
Restricted cash	16,934	5,692
Marketable securities	6,542,667	8,304,392
Other current assets and prepaid expenses	788,409	59,249
Total current assets	8,688,213	9,101,875
Licensing right to use technology	495,000
Property and equipment, net	244,872	253,184
TOTAL ASSETS	9,428,085	9,355,059
Current liabilities
Accounts payable	1,164,672	842,039
Accrued expenses	1,533,102	1,257,762
Deferred revenue	2,263,294
Stock to be issued to a vendor	144,000
Loans from related parties and others	34,536	33,124
Loan payable	263,604
Total current liabilities	5,403,208	2,132,925
Liabilities related to warrants		5,677,934
Total long-term liabilities	0	5,677,934
Commitments and contingencies
Shareholders' equity
Preferred Stock, $0.0001 par value per share: 10,000,000 shares authorized, 0 shares issued and outstanding
Common Stock, $0.0001 par value per share: 100,000,000 shares authorized, 8,714,815 and 8,397,056 shares issued and outstanding as of March 31, 2019 and March 31, 2018, respectively	871	840
Treasury stock	(25,000)	(25,000)
Additional paid-in capital	41,693,578	32,141,110
Accumulated deficit	(37,644,572)	(30,569,764)
Accumulated other comprehensive loss		(2,986)
Total shareholders' equity	4,024,877	1,544,200
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 9,428,085	$ 9,355,059